Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.15 is 13% below its 5-year average of -2.78, near the low end of its 5-year range (-3.38–-1.75).
2.33% above its 12-month average of -3.22.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -0.72.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.15
EARNINGS PER SHARE (EPS) AVG TTM
-3.22
EARNINGS PER SHARE (EPS) AVG 3Y
-3.17
EARNINGS PER SHARE (EPS) AVG 5Y
-2.78
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.33%
CURRENT VS 3Y AVG
+0.63%
CURRENT VS 5Y AVG
-13.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Replimune Group, Inc.
Market Cap
$1.11B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.22
3Y Avg
-3.17
5Y Avg
-2.78
Market Cap
$1.10B
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.19
3Y Avg
-0.27
5Y Avg
-0.18
Market Cap
$1.10B
Earnings Per Share (EPS)
0.08
TTM Avg
-1.62
3Y Avg
-0.53
5Y Avg
-0.05
Market Cap
$1.11B
Earnings Per Share (EPS)
-0.93
TTM Avg
-2.25
3Y Avg
-2.35
5Y Avg
-1.62
Market Cap
$1.10B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.05
3Y Avg
-3.05
5Y Avg
-3.05
Market Cap
$1.09B
Earnings Per Share (EPS)
-3.10
TTM Avg
-1.89
3Y Avg
-1.38
5Y Avg
-1.38
Market Cap
$1.13B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.04
3Y Avg
-2.04
5Y Avg
-2.04
Market Cap
$1.08B
Earnings Per Share (EPS)
1.79
TTM Avg
1.65
3Y Avg
1.42
5Y Avg
1.09
Market Cap
$1.13B
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.32
3Y Avg
-0.47
5Y Avg
-0.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.11B | -3.15 | -3.22 | -3.17 | -2.78 |
| OPKO Health, Inc. (OPK)vs › | $1.10B | -0.10 | -0.19 | -0.27 | -0.18 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.08 | -1.62 | -0.53 | -0.05 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -0.93 | -2.25 | -2.35 | -1.62 |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | N/A | -3.05 | -3.05 | -3.05 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -3.10 | -1.89 | -1.38 | -1.38 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | -2.04 | -2.04 | -2.04 |
| IRadimed Corporation (IRMD)vs › | $1.08B | 1.79 | 1.65 | 1.42 | 1.09 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -0.99 | -0.32 | -0.47 | -0.45 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 1.69 | 2.70 | 2.53 | 1.91 |
Trailing EPS (TTM)
$-3.15
Forward EPS (Est.)
$-2.89
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -3.38 |
| 2025-03-31 | -3.07 |
| 2024-03-31 | -3.24 |
| 2023-03-31 | -2.99 |
| 2022-03-31 | -2.26 |
| 2021-03-31 | -1.75 |
| 2020-03-31 | -1.54 |
| 2019-03-31 | -1.33 |
| 2018-03-31 | -0.64 |
| 2017-03-31 | -0.36 |
